18% of GDP, worst outcomes in the OECD
That spending runs $1 trillion/year more than any peer nation's, and the outcome gap spans life expectancy, infant mortality, maternal mortality, and chronic disease burden. 28M uninsured. 45M underinsured. Family premiums average $23,968/yr. Workers earning $60K spend 20%+ of income on healthcare once cost-sharing and denials are counted. Hospital consolidation has eliminated competition in 75% of metropolitan markets. Defensive medicine — tests ordered primarily to avoid malpractice liability — costs $200–300B/yr. Billing administration and coverage denial operate as tolls on care itself; the Accord retires both by design.
The incentive structure is wrong at every level: fee-for-service rewards volume, not outcomes. CMS projects 20.3% of GDP by 2033 under the status quo. Every other developed nation achieves better outcomes at 9–12% of GDP.
Comprehensive across categories — $0 premiums for the floor
Enrollment is automatic, from birth, and deductibles are $0 as well — supplemental tiers are separately priced. Coverage spans medical, mental health, SUD, maternity, and prescription care; point-of-care cost sharing (copays, sliding scales, low-income waivers) is set by AHQB evidence, not by billing codes. The table states the boundary plainly:
- Hospital care — inpatient and outpatient
- Emergency care
- Primary care
- Specialty referral
- Maternity and newborn care
- Mental health and substance-use treatment
- Prescription drugs on the AHQB formulary
- Preventive care with $0 cost sharing
- Basic dental prevention + emergency extraction
- Emergency vision exam
- Hearing screening
- Capacity payments for rural trauma + pandemic readiness
- Reduced or zero point-of-care cost sharing
- Comprehensive adult dental
- Vision correction (exams, lenses, frames)
- Hearing aids
- Private room where available
- Faster elective scheduling — within the same wait-time ceiling
- Premium prosthetics
- Employer may pay it as a benefit — taxed as compensation, no new exclusion
One single federal payer pays three delivery lanes for the floor. All three run on AHQB-set rates and standards; the mix in any region follows local capacity, geography, and population.
Independent hospitals, clinics, FQHCs, and physician practices on AHQB fee schedules — private insurers today pay hospitals ~254% of Medicare rates (RAND). The standup follows Maryland's all-payer model, the tested on-ramp.
Multi-specialty integrated systems contracted at capitated rates with a service-area enrollment obligation: the contractor serves the full population in its catchment, not the healthier subset.
Existing Veterans Health Administration infrastructure scales to non-veterans — government-operated facilities and salaried clinicians, paid by the same single payer.
Optional supplemental — a financial layer, not a second tier of care
Above the floor sits a regulated supplemental market on the pattern ~65 million Medicare households already know from Medigap. It is a financial and convenience enhancement on the same clinical floor: reduced or zero point-of-care cost sharing, a private room where available, faster elective scheduling within the same wait-time ceiling, comprehensive adult dental, vision correction, hearing aids, premium prosthetics. Same doctors, same AHQB standards — supplemental does not buy anyone out of the system, and no plan can offer a different standard of clinical care.
The market is community-rated and guaranteed issue with no medical underwriting: premiums vary only by age and geography within statutory bands, never by health status, and no one can be turned away. Plans are standardized into comparable tiers under AHQB supervision — a comparison table, not a confusion market. An individual can buy a tier directly, or an employer can pay for one as a benefit — taxed as ordinary compensation, with no new exclusion: rebuilding the employer-insurance tax exclusion would rebuild the distortion this architecture removes.
The one-way ratchet. The AHQB charter requires an annual review of whether any supplemental benefit should migrate into the floor — the test is falling unit cost or strengthened clinical evidence, and migration only ever runs toward the floor, never out of it. (Illustrative: a benefit like hearing aids becomes a migration candidate once reference pricing has cut its unit cost — whether and when is the Board's evidence-based call, made under its published, appealable process.) That is why the cost headline is a ~13% GDP Phase-1 floor falling toward ~12% as the floor absorbs more benefits at lower unit costs.
AHQB authority, the 16.8% Cost Brake, and the three-axis rollout
The American Healthcare Quality Board is structured like the Federal Reserve — independent, Senate-confirmed with staggered terms, insulated from political direction. It holds three authorities over the floor: safe-harbor clinical guidelines (documented protocol compliance is a complete statutory defense against malpractice liability, ending the $200–300B/yr defensive-medicine tax); reference pricing at 120% of an international benchmark (drawn annually from Germany, Canada, Australia, France, Japan, UK, and the Nordics — the VA has run this for pharmaceuticals since the 1990s at 40–70% below commercial prices); and evidence-based coverage and cost-sharing decisions with published rationale, comment periods, and formal appeal rights for every limitation. It also supervises the supplemental market's tier standardization and rating rules, and runs the annual floor-migration review. The Healthcare Cost Brake is one of the five macrogovernors: when Distributed Healthcare costs exceed 16.8% of GDP, an AHQB fee clawback (0–2%) activates automatically — a cost-side action only. Only if that containment fails does the Debt Sunset Governor fire.
The rollout phases who enrolls when — never the rate. When a tranche goes live, its workers move onto the floor and its payroll levy replaces FICA plus premiums at the full 28% (10.5% employee / 17.5% employer) from its first day — there is no reduced introductory rate, for anyone, ever. Tranche assignment runs over 6–8 years on employer size and average payroll and on region (enrollment follows delivery capacity — VHA and Post Office 2.0 site density plus the COMPASS shortage score — with a quarterly published readiness map); the NSB and AHQB hold rule-making authority to add a benefits-level axis. Three size tranches:
Self-employed, gig workers, employers under 20 workers, and every currently uninsured American.
Employers of 20–500 workers.
Employers over 500 workers, plus the federal workforce.
The enrollment-priority order is statutory — deliberately the inverse of the usual protect-the-comfortable-incumbents pattern, and built so no governor can game it:
By benefit composition, the floor launches comprehensive across categories as listed above, and widens only through the one-way ratchet. Every region-tranche cell is gated on four capacity metrics — a failed gate pauses that region and tranche only, never the national rollout:
- Provider availability per 10,000 enrollees
- Wait-time stability — no more than +10% over any 90 days
- No increase in emergency-department diversion
- AHQB quality-metric stability